Competitive Technologies Inc. (CTTC.PK) announced that it has negotiated a five-year extension to its agreement for the Calmare pain therapy device utilizing "Scrambler Therapy" technology.
The agreement with Giuseppe Marineo and Delta Research & Development, dated April 1, 2011, provided a five-year term expiring March 30, 2016 which has now been extended to March 30, 2021.
In a related decision, CTTC has chosen to concentrate its sales and marketing programs for the Calmare device primarily in the Western Hemisphere including the USA, Canada, Mexico and the countries of Central and South America, as well as Australia and New Zealand.
For comments and feedback: editorial@rttnews.com